Home / People / James Parkes
Portrait of James Parkes

James Parkes

Partner

CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
Languages English

James Parkes is a partner in the Corporate Transactions group. He advises UK and international clients on a broad range of transactions, including domestic and cross-border M&A (public and private), joint ventures, restructuring and financing transactions. His clients span a number of industry sectors, including consumer and retail, real estate, TMT, sports, hospitality and leisure, and life sciences. James specialises in advising corporates, financial sponsors and investment banks on transactions undertaken on the UK equity capital markets (both the Main Market and AIM).

James has been recognised as a leading practitioner by Chambers and Partners and Legal 500.

more less

“A star of the future… James is very calm under pressure and very to the point”

Chambers & Partners

Relevant experience

  • Galliford Try on its GBP 1.075 bn sale of its Linden Homes and Partnerships & Regeneration businesses to Vistry.
  • L&G Capital Investments on the GBP 352m Main Market IPO of Pod Point.
  • Hollywood Bowl on its GBP 240m Main Market IPO and secondary equity fundraisings.
  • Strix on its GBP 190m AIM IPO and EUR 31.6m acquisition of Laica.
  • Big Yellow on its £100m equity fundraise and £145m acquisition of Armadillo Self Storage.
  • Galliford Try on its GBP 157m ‘cash-box’ rights issue.
  • LondonMetric Property on its GBP 415m recommended takeover of A&J Mucklow.
  • Liberum on the GBP 73m AIM IPO of Aquis Exchange.
  • Panmure Gordon on the GBP 20m AIM IPO of Arecor Therapeutics.
  • RBS on the GBP 53m public company acquisition of FreeAgent.
  • The management of Harvey Nash in relation to its GBP 98m acquisition by The Power of Talent.
  • Mayfair Equity Partners on its GBP 79m recommended offer for Nasstar.
  • The All England Lawn Tennis Ground on its Centre Court and No. 1 Court Debenture Issues and its GBP £65m acquisition of The Wimbledon Park Golf Club.
  • CooperSurgical on its GBP 140m acquisition of the Wallace line of IVF products from Smiths Medical and GBP 47.5m acquisition of Safe Obstetrics Systems.
more less

Education

  • 2000 - LPC (Distinction), College of Law, London
  • 1999 - BA Law & History (Joint Hons), University College London, London
more less

Feed

15/11/2022
Ad­vising the Board Re­port on Dir­ect­or Du­ties Risk
Ex­ec­ut­ive and non-ex­ec­ut­ive dir­ect­ors have a wealth of re­spons­ib­il­it­ies, but no mat­ter the nature of a par­tic­u­lar role or in­dustry, or the day to day de­mands of a busi­ness, all dir­ect­ors re­main sub­ject...
29/07/2022
The fu­ture of UK Sec­ond­ary Fun­drais­ings
The long-an­ti­cip­ated UK Sec­ond­ary Cap­it­al Rais­ing Re­view has landed. The Re­view was led by Fresh­fields part­ner, Mark Aus­tin, fol­low­ing con­sulta­tion with nu­mer­ous mar­ket par­ti­cipants. The Re­view fol­lows...
28/06/2021
CMS ad­vises cli­ents in re­la­tion to AIM IPO and re­verse ac­quis­i­tion
In­ter­na­tion­al law firm CMS has ad­vised on two equity cap­it­al mar­ket trans­ac­tions in re­cent weeks. CMS ac­ted for Pan­mure Gor­don as nom­in­ated ad­viser and sole broker to Are­cor Thera­peut­ics plc in re­la­tion...
23/04/2020
CMS tops UK ECM trans­ac­tions leg­al ad­viser rank­ings
CMS has ad­vised on five sep­ar­ate pla­cings for lis­ted com­pan­ies in the past week, re­in­for­cing the firm’s po­s­i­tion as the joint most act­ive leg­al ad­viser on ECM trans­ac­tions in Q1 2020 ac­cord­ing to ECM...
03/04/2020
Pre-Emption Group pub­lishes ex­pect­a­tions for is­su­ances in the cir­cum­stances...
On 1 April 2020, the Fin­an­cial Re­port­ing Coun­cil pub­lished a state­ment on be­half of the Pre-Emption Group (PEG) set­ting-out the PEG’s ex­pect­a­tions for is­su­ances dur­ing the eco­nom­ic tur­bu­lence caused...
01/04/2020
Guid­ance on Tem­por­ary Meas­ures for AGMs – an up­date for UK pub­lic com­pan­ies
Fur­ther to the UK Gov­ern­ment’s en­act­ment of le­gis­la­tion on 23 March 2020 re­quir­ing all non-key per­son­nel to “stay at home” (the “Stay At Home Meas­ures”), The Chartered Gov­ernance In­sti­tute...
26/03/2020
Ex­ten­sions to dead­lines for pub­lish­ing and fil­ing an­nu­al ac­counts and ad­di­tion­al...
In a com­bined ap­proach, the FCA, Lon­don Stock Ex­change and Com­pan­ies House have an­nounced a series of meas­ures ex­tend­ing the dead­lines for both the pub­lic­a­tion of fin­an­cial res­ults by lis­ted com­pan­ies...
23/03/2020
Tem­por­ary Coronavir­us Meas­ures for AIM com­pan­ies and Nomads
Cor­rect as of 10 am 23 March 2020. This art­icle is not be­ing main­tained. We pre­vi­ously pub­lished a Law-Now high­light­ing some of the po­ten­tial con­sequences of the spread of Coronavir­us for UK pub­lic com­pan­ies...
16/03/2020
AGMs in the time of Coronavir­us -con­sid­er­a­tions for UK pub­lic com­pan­ies
While it is dif­fi­cult to an­ti­cip­ate the prac­tic­al ef­fects of the con­tin­ued spread of nov­el Coronavir­us (“COV­ID-19”) in the UK, the po­ten­tial for gov­ern­ment-man­dated re­stric­tions on travel or pub­lic...
11/03/2020
En­quiry Let­ters from the FCA - In­vest­ig­a­tions in­to Mar­ket An­nounce­ments...
The FCA has re­spons­ib­il­ity for mon­it­or­ing the ac­cur­acy and timeli­ness of pub­lic an­nounce­ments made by pub­lic com­pan­ies with shares ad­mit­ted to list­ing or trad­ing (on the Of­fi­cial List, AIM and the Spe­cial­ist...
11/11/2019
CMS ad­vises Gal­li­ford Try on £1.1bn house­build­ing com­bin­a­tion with Bovis...
In­ter­na­tion­al law firm CMS has ad­vised Brit­ish con­struc­tion and house-build­ing group, Gal­li­ford Try, in re­la­tion to its land­mark trans­ac­tion to com­bine its Linden Homes and Gal­li­ford Try Part­ner­ships...
16/07/2018
ECM Mar­ket Re­view June 2018
The CMS ECM Mar­ket Re­view is a sum­mary of re­cent events in some of the key sec­tors that we fo­cus on.It is now just over a year since the mer­ger which cre­ated CMS Camer­on McK­enna Nabarro Olswang and its...